704 related articles for article (PubMed ID: 6492900)
21. Effect of excitotoxin lesions in the medical prefrontal cortex on cortical and subcortical catecholamine turnover in the rat.
Christie MJ; Rowe PJ; Beart PM
J Neurochem; 1986 Nov; 47(5):1593-7. PubMed ID: 3531406
[TBL] [Abstract][Full Text] [Related]
22. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
23. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
Zaman V; Nelson ME; Gerhardt GA; Rohrer B
Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
[TBL] [Abstract][Full Text] [Related]
24. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
Moore AE; Cicchetti F; Hennen J; Isacson O
Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
[TBL] [Abstract][Full Text] [Related]
25. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems.
Andersson K; Fuxe K; Agnati LF; Eneroth P
Med Biol; 1981 Jun; 59(3):170-6. PubMed ID: 6458747
[TBL] [Abstract][Full Text] [Related]
26. Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents.
Diop L; Gottberg E; Brière R; Grondin L; Reader TA
Synapse; 1988; 2(4):395-405. PubMed ID: 2973141
[TBL] [Abstract][Full Text] [Related]
27. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Nissbrandt H; Carlsson A
J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
[TBL] [Abstract][Full Text] [Related]
28. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
Walsh FX; Stevens TJ; Langlais PJ; Bird ED
Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
[TBL] [Abstract][Full Text] [Related]
29. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
Attila LM; Ahtee L
Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
[TBL] [Abstract][Full Text] [Related]
30. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
[TBL] [Abstract][Full Text] [Related]
31. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
32. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
[TBL] [Abstract][Full Text] [Related]
33. Dopamine in thelimbic regions of the human brain: normal and abnormal.
Farley IJ; Price KS; Hornykiewicz O
Adv Biochem Psychopharmacol; 1977; 16():57-64. PubMed ID: 883559
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine decreases catecholamine turnover in the rat brain.
Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
[TBL] [Abstract][Full Text] [Related]
35. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
[TBL] [Abstract][Full Text] [Related]
36. [Study of the turnover or the release of brain dopamine in rats after administration of N-linoleyl dopamine].
Papadopoulou-Daïfoti Z; Sakellariou A; Raftopoulos C; Vamvakidès A
Ann Pharm Fr; 1992; 50(4):229-36. PubMed ID: 1306617
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
38. An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis.
Sharp T; Zetterström T; Ungerstedt U
J Neurochem; 1986 Jul; 47(1):113-22. PubMed ID: 3711893
[TBL] [Abstract][Full Text] [Related]
39. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex.
Beauregard M; Ferron A; Descarries L
Synapse; 1991 Sep; 9(1):27-34. PubMed ID: 1839089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
